Scribe Therapeutics files for 7.15M share IPO at $13-$15/sh

Scribe Therapeutics Inc. has filed for an initial public offering of 7,150,000 shares of common stock, according to a press release statement from the company.

The biotechnology company anticipates pricing its shares between $13.00 and $15.00 per share. At the midpoint of that range, the offering would raise approximately $100 million.

Scribe Therapeutics has applied to list its common stock on the Nasdaq Global Market under the ticker symbol NASDAQ: SCTX. The closing of the offering is contingent upon the completion of the Nasdaq listing.

Leerink Partners, Goldman Sachs & Co. LLC, Guggenheim Securities, and Wells Fargo Securities are serving as underwriters for the offering.

You May Also Be Interested In

• Entrata (ENT) files for proposed IPO
• Datametrex AI to rename as Quanta AI, appoints new CEO and CFO
• 22nd Century Group targets 5,000 retail outlets by year-end